Jazz Pharmaceuticals JAZZ Options forfeited/expired (in dollars per share)
Options forfeited/expired (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice.
The official record: Jazz Pharmaceuticals’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's options forfeited/expired (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's options forfeited/expired (in dollars per share)?
- Jazz Pharmaceuticals (JAZZ) reported options forfeited/expired (in dollars per share) of $167.80 in Q4 2025.
- How has Jazz Pharmaceuticals's options forfeited/expired (in dollars per share) changed year-over-year?
- Jazz Pharmaceuticals's options forfeited/expired (in dollars per share) increased by 12.6% year-over-year, from $148.99 to $167.80.
- What does options forfeited/expired (in dollars per share) mean?
- The average price of stock options that were cancelled or expired.
- How do you interpret options forfeited/expired (in dollars per share)?
- Provides insight into the historical strike prices of options that failed to provide value to employees.
- How does options forfeited/expired (in dollars per share) compare across companies?
- Used by analysts to gauge the historical 'out-of-the-money' status of employee equity grants.